Want to join the conversation?
$FE 2Q15 Q&A: Fleishman from Wolfe Research asked about schedule on the filing on the MAIT approval in states Pennsylvania, New Jersey. Leila explained right now interventions were due by July 10, right now I don’t see any further procedural schedule set with regard to that, although we would expect a decision by Dec. 15.
No better outlook on $MSFT. Even if the results beat a bit, the stock may move 4 to 6% higher, but won't go above $60.